For Wayne Kristoff, the possibility of getting off all medication for his type 2 diabetes was so intriguing he jumped at a chance to participate in an innovative trial in London. The REMIT study aims to induce remission of the condition – an exciting new concept being tested by researchers at Lawson Health Research Institute.
On tour for CAHO’s visit to Lawson. From left: Dr. Gillian Kernaghan, President & CEO, St. Joseph’s; Murray Glendining, President & CEO, LHSC; MPP Jeff Yurek; MP Karen Vecchio; Karen Michell, Executive Director, CAHO; Dr. David Hill, Scientific Director, Lawson.
Dr. Glenn Bauman, Chair/Chief Department of Oncology, Lawson Scientist and Radiation Oncologist at LHSC, explains why enrollment in clinical trials is so important.
“Clinical trials generate the evidence we need to improve the care of our patients. They bring knowledge from the laboratory to care in the clinic.”
Starting February 3, you may see staff members and physicians at London Health Sciences Centre (LHSC) and St. Joseph’s Health Care London (St. Joseph’s) wearing “Ask me about clinical trials” buttons.